Retracted: Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction

Yongqing Han; Dayou Shi; Jingao Li

doi:10.12659/MSM.931623

Retracted: Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction

Med Sci Monit. 2021 Mar 11:27:e931623. doi: 10.12659/MSM.931623.

Authors

Yongqing Han¹, Dayou Shi², Jingao Li³

Affiliations

¹ Department of Oncology, Nanchang University, Nanchang, Jiangxi, China (mainland).
² Department of Oncology, Jiujiang First People's Hospital, Jiujiang, Jiangxi, China (mainland).
³ Department of Radiotherapy, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China (mainland).

Abstract

Approval for publication of this manuscript was not obtained by all the authors, which is in breach of this journal's editorial guidelines. Reference: Yongqing Han, Dayou Shi, Jingao Li: Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction. Med Sci Monit 2019; 25:8995-9002. 10.12659/MSM.915463.

Publication types

Retraction of Publication